FDA Leader Resigned After Push From Big Pharma. Now He’s Back. 

The Food and Drug Administration’s top vaccine and gene therapy regulator is back at his post after resigning late last month, reportedly due to a Big Pharma-backed campaign to remove him.

Dr. Vinay Prasad, the FDA’s Center for Biologics Evaluation and Research, resigned after he received negative attention online over past posts related to his personal politics.

“At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” Health and Human Services (HHS) spokesman Andrew Nixon said on Saturday.

Prasad is generally considered liberal, though he bucked COVID orthodoxy and criticized Dr. Anthony Fauci during the pandemic, winning him much praise from the Right and those in the Make America Healthy Again (MAHA) movement.

Reporting from Laura Loomer in July showcased past tweets from Prasad that Loomer suggested were evidence that Prasad is a “wolf in sheep’s clothing is sabotaging President Trump’s bold ‘Make America Healthy Again’ (MAHA) agenda.'”

🚨 ALERT 🚨

VINAY PRASAD, THE LEFTIST SABOTEUR UNDERMINING TRUMP’S @US_FDA, MUST BE FIRED NOW!

We have a crisis at the FDA! A wolf in sheep’s clothing is sabotaging President Trump’s bold “Make America Healthy Again” (MAHA) agenda! Dr. Vinay Prasad @VPrasadMDMPH, a… https://t.co/T2cjicFB38 pic.twitter.com/EydtOgXYVs

— Laura Loomer (@LauraLoomer) July 22, 2025

However, reports indicate Prasad was actually being targeted by some because of his decision to pause shipments of a gene therapy for Duchenne muscular dystrophy (DMD), which is produced by Sarepta Therapeutics, claiming the genetic treatment is linked to three potential deaths.

“Hit pieces on FDA’s Vinay Prasad are being fed to the right by pharma company Sarepta, the maker of an experimental drug that just killed an eight year old boy,” Daily Caller investigative reporter Emily Kopp reported on July 25.

Days later, Prasad resigned.

Hit pieces on FDA’s Vinay Prasad are being fed to the right by pharma company Sarepta, the maker of an experimental drug that just killed an eight year old boy. https://t.co/1wCq3ksXWZ pic.twitter.com/Y8aeRtqBU9

— Emily Kopp (@emilyakopp) July 25, 2025

FDA commissioner Dr. Marty Makary has spoken highly of Prasad and signaled last week that he was working to get Prasad back at the FDA — a feat he apparently achieved.

“The idea that he was pushed out by anybody is simply untrue,” Makary told the media. “He saw some media headlines and didn’t want to be a distraction.”

“We have encouraged him to reconsider, and we are still doing that,” he added. “I am confident the FDA is going to continue to be strong. The FDA is one of the greatest brands in the world, and it’s going to continue to do that.”

FDA Commissioner Marty Makary says he is trying to persuade Vinay Prasad — who left FDA amid a PR blitz by Sarepta Therapeutics and Laura Loomer — to rejoin FDA. 🤔 pic.twitter.com/mAZmJReMmk

— Emily Kopp (@emilyakopp) August 4, 2025

Related: FDA Shake-Up: The Controversial Ouster Of The Top Vaccine Regulator